Scolaris Content Display Scolaris Content Display

Cochrane Central Register of Controlled Trials

Efficacy of dolutegravir/abacavir/lamivudine (DTG/ABC/ 3TC) fixed-dose combination (FDC) compared with ritonavir-boosted atazanavir (ATV/r) plus tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) in treatment-naïve women with HIV-1 infection (ARIA study): subgroup analyses

Johnson M, Gatey C, Manosuthi W, Lazzarin A, Podzamczer D, Man C, Aylott A, Buchanan A, Wynne B, Vavro C, Aboud M, Smith K
Journal of the International AIDS Society, 2016, 19, 40‐41 | added to CENTRAL: 31 May 2017 | 2017 Issue 5
https://doi.org/10.7448/IAS.19.8.21487
Sourced from:
Embase
Unlock the abstract